EMA committee recommends approval of Eisai & Biogen’s lecanemab to treat early Alzheimer’s disease: Tokyo Saturday, November 16, 2024, 13:00 Hrs [IST] Eisai Co., Ltd. and Biog ...
Since its founding in 1874, The Accountant has evolved with the profession, from UK-focused beginnings to a global reach. We ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback